| Abstract | This review focuses on the use of angiotensin converting enzyme (ACE) inhibitors in hypertensive diseases. Specifically discussed are: proposed mechanisms of action, the pharmacology of the commercially available ACE inhibitors (captopril, enalapril, and lisinopril), their renal effects, and their safety and efficacy. The ACE inhibitors are assuming a dominant role in our therapeutic armamentarium, in that they are well-tolerated and very effective in the treatment of mild, moderate or severe hypertension. |
| Authors | J H Bauer
(Affiliation: Department of Medicine, University of Missouri, Columbia 65212.)
|
| Journal | American journal of hypertension : journal of the American Society of Hypertension
(Am J Hypertens)
Vol. 3
Issue 4
Pg. 331-7
(Apr 1990)
ISSN: 0895-7061 UNITED STATES |
| PMID | 2189445
(Publication Type: Journal Article, Review)
|
| Chemical References |
- Angiotensin-Converting Enzyme Inhibitors
|
| Topics |
- Angiotensin-Converting Enzyme Inhibitors
(adverse effects, therapeutic use)
- Humans
- Kidney
(drug effects)
|
